Functional Genomics of Chemical -Induced Acute Lung Injury
化学引起的急性肺损伤的功能基因组学
基本信息
- 批准号:7293573
- 负责人:
- 金额:$ 73.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-29 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcroleinAcute Lung InjuryAlveolarAlveolar CellAmmoniaAntioxidantsBindingBiochemicalCandidate Disease GeneCause of DeathCell ProliferationCell physiologyChemical ExposureChemicalsChlorineClinicalComplexConditionCritical IllnessDataDatabasesDevelopmentDiagnosisEarly DiagnosisEffectivenessElementsEmergency SituationEndopeptidasesEndothelial CellsEpidermal Growth Factor ReceptorEpithelialEpithelial CellsEpitheliumEquilibriumEventExposure toExtracellular MatrixEyeFGFR2 geneFibrinolysisFibroblastsFoundationsFunctional disorderGastrointestinal tract structureGene ExpressionGene Transfer TechniquesGenesGeneticGenetic DeterminismGenomeGoalsGrowthGrowth FactorHazardous ChemicalsHealedHeartHomeostasisHost DefenseHourIndividualInjuryIon TransportKnowledgeLaboratoriesLeadLeukocytesLinkLungMapsMediatingMediator of activation proteinMethodsModelingMolecularMolecular ProfilingMonitorMusNatural ImmunityNeuraxisNickelOrganOutcomeOzonePathway interactionsPatientsPeptide HydrolasesPhosgenePhospholipidsPlantsPlayPopulationPositioning AttributePredispositionProtein BiosynthesisProtein Tyrosine KinaseProteinsPulmonary EdemaPulmonary FibrosisRailroadsRegulationResearch PersonnelRespiratory FailureRespiratory physiologyRiskRoleSignal InductionSignal PathwaySignal TransductionSigns and SymptomsSingle Nucleotide Polymorphism MapStructural ProteinSulfuric AcidsTestingTherapeuticTimeTissue-Specific Gene ExpressionToxic effectTranscriptTransforming Growth Factor alphaTransforming Growth Factor betaTransgenic MiceTransgenic OrganismsTraumaTreatment EfficacyTriageWeekWorkWound Healingbasedaydesignfunctional genomicsfunctional restorationgenetic linkage analysisgenome wide association studyhealingimprovedinjury and repairinnovationinsightkeratinocyte growth factorlung injurymortalitymouse modelnovelnovel therapeuticsoutcome forecastprognosticprogramsprotein Breceptorresponsesurfactant
项目摘要
Even without signs of external injury, chemical exposure can produce severe trauma to internal target
organs including the lungs, heart, gastrointestinal tract, eyes, and the central nervous system. Of these
injuries, the extent of lung injury often is the most critical to survival. Chemical Induced Acute Lung Injury
(CIALI) can be viewed as a molecular cascade mounting over hours and days subsequent to even a
transient incident. Unfortunately, CIALI is a likely consequence of terrorist attacks of multiple possible
scenarios including intentional detonation of chemical plants, railroad car derailment, or chemical truck
hijacking. Chemicals of high concern include chlorine, phosgene, sulfuric acid, ammonia, and acrolein.
Predictive strategies will require the monitoring of multiple biochemical indicators forming complex molecular
signatures. Our goal is to understand the genetic, global transcriptomal, and molecular events that will
provide insights into the mechanisms of CIALI and could redirect or strengthen current emergency clinical
approaches to diagnosis and treatment. The objective of this application is to determine the molecular
mechanism(s) and therapeutic efficacy of TGFalpha and FGF7 in enhancing survival in this condition. Our
central hypothesis is that the interplay between TGFalpha, FGF7, and TGFbeta signaling determines
survival and controls the susceptibility to sequelae from CIALI. To explore our hypothesis, we seek to:
1) Identify the genetic determinants and molecular mechanisms controlling CIALI common to exposure to 5
leading hazardous chemicals: chlorine, phosgene, sulfuric acid, ammonia, and acrolein, 2) Evaluate the
therapeutic efficacy of TGFalpha and FGF7 induction and signaling during CIALI and determine whether
pulmonary fibrosis is a necessary sequela as a consequence of protection, and 3) Identify the molecular
mechanisms that are unique to each of the 5 leading hazardous chemicals during the early development of
CIALI. At the completion of this project, we expect to: 1) Identify novel genetic differences that determine the
susceptibility to CIALI, 2) Identify the events modulated during CIALI that are common to multiple agents 3)
Evaluate the effectiveness of therapies by that lead to protection in CIALI, 4) Determine whether pulmonary
fibrosis is an untoward consequence of activating TGFalpha/FGF7signaling during CIALI, 5) Develop an
initial chemical specific database on the selective signatures of the 5 leading hazardous chemicals.
即使没有外伤迹象,化学品暴露也会对内部目标造成严重创伤
器官包括肺、心脏、胃肠道、眼睛和中枢神经系统。其中
受伤时,肺损伤的程度往往对生存最为关键。化学引起的急性肺损伤
(CIALI) 可以被视为分子级联,即使在一个
短暂的事件。不幸的是,CIALI 很可能是多种可能的恐怖袭击的结果
包括故意爆炸化工厂、火车车厢脱轨或化学品卡车等场景
劫持。高度关注的化学品包括氯、光气、硫酸、氨和丙烯醛。
预测策略将需要监测形成复杂分子的多种生化指标
签名。我们的目标是了解遗传、全局转录和分子事件,这些事件将
提供对 CIALI 机制的见解,并可以重定向或加强当前的紧急临床
诊断和治疗的方法。本应用的目的是确定分子
TGFα 和 FGF7 在提高这种情况下的生存率方面的机制和治疗效果。我们的
中心假设是 TGFα、FGF7 和 TGFβ 信号传导之间的相互作用决定了
生存并控制对 CIALI 后遗症的易感性。为了探索我们的假设,我们寻求:
1) 确定暴露于 5 种常见的控制 CIALI 的遗传决定因素和分子机制
主要危险化学品:氯、光气、硫酸、氨、丙烯醛,2)评估
CIALI 期间 TGFα 和 FGF7 诱导和信号传导的治疗效果,并确定是否
肺纤维化是保护的必然后遗症,并且 3) 识别分子
5种主要危险化学品在早期开发过程中各自独特的机制
恰利。在该项目完成时,我们期望: 1)确定新的遗传差异,这些差异决定了
对 CIALI 的敏感性,2) 识别在 CIALI 期间调制的多个代理共有的事件 3)
通过对 CIALI 产生保护作用来评估治疗的有效性,4) 确定肺部是否
纤维化是 CIALI 期间激活 TGFalpha/FGF7 信号传导的不良后果,5) 开发
关于 5 种主要危险化学品的选择性特征的初始化学品特定数据库。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George Douglas Leikauf其他文献
George Douglas Leikauf的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George Douglas Leikauf', 18)}}的其他基金
Pathophysiological Mechanisms of Chemical-Induced Acute Lung Injury
化学引起的急性肺损伤的病理生理机制
- 批准号:
10708438 - 财政年份:2023
- 资助金额:
$ 73.86万 - 项目类别:
Improving our mechanistic understanding of Electronic-cigarette, or vaping, product use-associated lung injury
提高我们对电子烟或电子烟产品使用相关肺损伤的机制理解
- 批准号:
10115186 - 财政年份:2020
- 资助金额:
$ 73.86万 - 项目类别:
Role of Metalloproteinases in Mucin Overproduction in COPD
金属蛋白酶在慢性阻塞性肺病粘蛋白过量产生中的作用
- 批准号:
7581036 - 财政年份:2008
- 资助金额:
$ 73.86万 - 项目类别:
Role of Metalloproteinases in Mucin Overproduction in COPD
金属蛋白酶在慢性阻塞性肺病粘蛋白过量产生中的作用
- 批准号:
7581036 - 财政年份:2008
- 资助金额:
$ 73.86万 - 项目类别:
Role of Metalloproteinases in Mucin Overproduction in COPD
金属蛋白酶在慢性阻塞性肺病粘蛋白过量产生中的作用
- 批准号:
7461274 - 财政年份:2008
- 资助金额:
$ 73.86万 - 项目类别:
Role of Metalloproteinases in Mucin Overproduction in COPD
金属蛋白酶在慢性阻塞性肺病粘蛋白过量产生中的作用
- 批准号:
7783818 - 财政年份:2008
- 资助金额:
$ 73.86万 - 项目类别:
Functional Genomics of Chemical -Induced Acute Lung Injury
化学引起的急性肺损伤的功能基因组学
- 批准号:
7224694 - 财政年份:2006
- 资助金额:
$ 73.86万 - 项目类别:
Functional Genomics of Chemical-Induced Acute Lung Injury
化学引起的急性肺损伤的功能基因组学
- 批准号:
8144632 - 财政年份:2006
- 资助金额:
$ 73.86万 - 项目类别:
相似国自然基金
Galectin-1抑制肺泡巨噬细胞线粒体损伤介导的NLRP3活化减轻流感致急性肺损伤的机制研究
- 批准号:82300005
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于“糖原合成-UDPG/P2Y14/STAT1-肺泡巨噬细胞M1型极化”途径探讨热炎宁合剂治疗急性肺损伤的作用机制
- 批准号:82374418
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
靶向HMGB1的WGA-siRNA纳米生物材料抑制肺泡巨噬细胞焦亡在烧伤脓毒症急性肺损伤的作用和分子机制
- 批准号:82372517
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
急性肺损伤中Hippo通路调控肺泡中间过渡态上皮细胞再生分化机制研究
- 批准号:82372185
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SIRT5-线粒体代谢轴失调介导SORT1Hi肺泡巨噬细胞METs形成在围术期急性肺损伤中的作用及机制研究
- 批准号:82371292
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Pathophysiological Mechanisms of Chemical-Induced Acute Lung Injury
化学引起的急性肺损伤的病理生理机制
- 批准号:
10708438 - 财政年份:2023
- 资助金额:
$ 73.86万 - 项目类别:
Cellular and molecular mechanisms of e-cigarette vaping-induced acute lung injury
电子烟引起急性肺损伤的细胞和分子机制
- 批准号:
10690279 - 财政年份:2022
- 资助金额:
$ 73.86万 - 项目类别:
Improving our mechanistic understanding of Electronic-cigarette, or vaping, product use-associated lung injury
提高我们对电子烟或电子烟产品使用相关肺损伤的机制理解
- 批准号:
10115186 - 财政年份:2020
- 资助金额:
$ 73.86万 - 项目类别: